Quantrx Biomedical CorpOver The Counter Market:QTXB
- LAST PRICE0.0040
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0040
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Quantrx Biomedical Corp | 314.8K | -1.2x | --- |
Micro Imaging Technology Inc | 2.7K | 0.0x | --- |
Xcorporeal Inc | 20.0 | 0.0x | --- |
Point of Care Nano-Technology Inc | 4.2K | -0.1x | --- |
Nanomix Corp | 4.9K | 0.0x | --- |
Biolife Sciences Inc | 3.2K | 0.0x | --- |
Company Information
QuantRx Biomedical Corporation has developed its patented miniform pads and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs (the OTC Business). The Company is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents (the Diagnostics Business). The Company's platforms include inSync, Unique and original equipment manufacturer (OEM) branded over-the-counter and laboratory testing products based on its core intellectual property related to the Company PAD technology. Its OTC Business includes commercialization of its InSync feminine hygienic interlabial pad, the Unique Miniform for hemorrhoid application, and other treated miniforms, as well as maintaining established and continuing licensing relationships related to the OTC Business. It also owns certain diagnostic testing technology that is based on its lateral flow patents.
Contact Information
- Headquarters
- 10190 SW 90th AvenueTUALATIN, OR, United States 97062
- Phone
- 212-980-2235
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer, Principal Accounting Officer
- Shalom Hirschman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $314.8K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -2.10 |
EPS | $0.00 |
Book Value | $-0.03 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
